UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Tg2576 mice have defective lipoprotein endocytosis

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S249-S249

2010

Volltextzugriff (PDF)

Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P109-P110

2009

Volltextzugriff (PDF)

The LXR agonist TO901317 selectively lowers hippocampal A beta 42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

Molecular and cellular neuroscience, 2007-04, Vol.34 (4), p.621-628

2007

Volltextzugriff (PDF)

BACE1 is not the rate-limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P430-P430

2009

Volltextzugriff (PDF)

P1-055: Impaired induction of neuronal immediate-early gene expression correlates with contextual memory deficits in APP transgenic mice

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T222-T222

2008

Volltextzugriff (PDF)

P2-306: Activation of both LXRα and LXRβ is required for TO901317-mediated lowering of Aβ42: implications for the development of Alzheimer's therapeutics

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T462-T462

2008

Volltextzugriff (PDF)

Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease

The Journal of neuroscience, 2005-09, Vol.25 (39), p.8898-8902

2005

Volltextzugriff (PDF)

P.3.d.019 Vabicaserin: effects of a novel 5-HT2C agonist on medial prefrontal cortex neurotransmission, cognition and sensorimotor gating

European neuropsychopharmacology, 2007, Vol.17, p.S484-S484

2007

Volltextzugriff (PDF)

Tyrosine Kinase Activity Is Essential for Interleukin‐1β‐Stimulated Production of Interleukin‐6 in U373 Human Astrocytoma Cells

Journal of neurochemistry, 1995-12, Vol.65 (6), p.2491-2499

1995

Volltextzugriff (PDF)

In vitro pharmacological characterization and pro-cognitive effects of the selective alpha-7 nicotinic agonist WYE-103914

Biochemical pharmacology, 2009-10, Vol.78 (7), p.911-911

2009

Volltextzugriff (PDF)

P1‐260: Tg2576 mice have defective lipoprotein endocytosis

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_8), p.S249-S249

2010

Volltextzugriff (PDF)

O2‐04‐02: Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_4), p.P109-P110

2009

Volltextzugriff (PDF)

P3‐296: BACE1 is not the rate‐limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_14), p.P430-P430

2009

Volltextzugriff (PDF)

Additive effects of basic fibroblast growth factor and phorbol ester on β-amyloid precursor protein expression and secretion: Cytokines in the nervous system

Neurochemistry international, 1997, Vol.30 (4-5), p.475-481

1997

Volltextzugriff (PDF)

ADDITIVE EFFECTS OF BASIC FIBROBLAST GROWTH FACTOR AND PHORBOL ESTER ON β-AMYLOID PRECURSOR PROTEIN EXPRESSION AND SECRETION

Neurochemistry international, 1997-04, Vol.30 (4), p.475-481

1997

Volltextzugriff (PDF)

Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?

Neurobiology of aging, 1992-09, Vol.13 (5), p.591

1992

Volltextzugriff (PDF)

Intracerebral β-amyloid(25-35) produces tissue damage : is it neurotoxic ?: Is β-amyloid neurotoxic ?

Neurobiology of aging, 1992, Vol.13 (5), p.591-594

1992

Volltextzugriff (PDF)

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

The Journal of neuroscience, 2008-11, Vol.28 (45), p.11445-11453

2008

Volltextzugriff (PDF)

ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer’s Disease

Cell reports (Cambridge), 2017-07, Vol.20 (2), p.344-355

2017

Volltextzugriff (PDF)

The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

Molecular and cellular neuroscience, 2007-04, Vol.34 (4), p.621-628

2007

Volltextzugriff (PDF)

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

Proceedings of the National Academy of Sciences - PNAS, 2008-06, Vol.105 (25), p.8754-8759

2008

Volltextzugriff (PDF)

Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer’s disease

Neurobiology of aging, 2016-08, Vol.44, p.96-107

2016

Volltextzugriff (PDF)

2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one Derivatives as Potent and Selective Histamine-3 Receptor Antagonists

Journal of medicinal chemistry, 2012-03, Vol.55 (5), p.2452-2468

2012

Volltextzugriff (PDF)

Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease

The Journal of pharmacology and experimental therapeutics, 2009-11, Vol.331 (2), p.598

2009

Volltextzugriff (PDF)

Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease

Journal of medicinal chemistry, 2008-12, Vol.51 (23), p.7348-7351

2008

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Animals
(17)
Humans
(13)
Neurology
(11)
Pharmacology & Pharmacy
(10)
Chemistry, Medicinal
(9)
Mice
(9)
Alzheimer's Disease
(8)
Biological And Medical Sciences
(8)
Male
(8)
Mice, Transgenic
(8)
Rats
(8)
Neurosciences
(7)
Neurosciences & Neurology
(7)
Structure-Activity Relationship
(7)
Alzheimer Disease - Drug Therapy
(6)
Amyloid Beta-Peptides - Metabolism
(6)
Amyloid Precursor Protein Secretases - Antagonists & Inhibitors
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tg2576 mice have defective lipoprotein endocytosis

Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice

The LXR agonist TO901317 selectively lowers hippocampal A beta 42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

BACE1 is not the rate-limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors

P1-055: Impaired induction of neuronal immediate-early gene expression correlates with contextual memory deficits in APP transgenic mice

P2-306: Activation of both LXRα and LXRβ is required for TO901317-mediated lowering of Aβ42: implications for the development of Alzheimer's therapeutics

Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease

P.3.d.019 Vabicaserin: effects of a novel 5-HT2C agonist on medial prefrontal cortex neurotransmission, cognition and sensorimotor gating

Tyrosine Kinase Activity Is Essential for Interleukin‐1β‐Stimulated Production of Interleukin‐6 in U373 Human Astrocytoma Cells

In vitro pharmacological characterization and pro-cognitive effects of the selective alpha-7 nicotinic agonist WYE-103914

P1‐260: Tg2576 mice have defective lipoprotein endocytosis

O2‐04‐02: Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice

P3‐296: BACE1 is not the rate‐limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors

Additive effects of basic fibroblast growth factor and phorbol ester on β-amyloid precursor protein expression and secretion: Cytokines in the nervous system

ADDITIVE EFFECTS OF BASIC FIBROBLAST GROWTH FACTOR AND PHORBOL ESTER ON β-AMYLOID PRECURSOR PROTEIN EXPRESSION AND SECRETION

Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?

Intracerebral β-amyloid(25-35) produces tissue damage : is it neurotoxic ?: Is β-amyloid neurotoxic ?

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer’s Disease

The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer’s disease

2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one Derivatives as Potent and Selective Histamine-3 Receptor Antagonists

Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease

Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease

Suchergebnisse filtern